Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Efficacy, Immunogenicity and Safety of adjuvanted Herpes Zoster-Virus Subunit Vaccine Candidates in Adults from 60 Years and older: Results from the Efficacy Studies ZOE-50 and ZOE-70
Hlth Sci North Res Inst, CAN.
GlaxoSmithKline, King Of Prussia, PA USA..
Westmead & Univ Sydney, AUS.
Univ Colorado Anschutz Med Campus, USA.
Show others and affiliations
2018 (English)In: Der Internist, ISSN 0020-9554, E-ISSN 1432-1289, Vol. 59, p. S64-S65Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
SPRINGER , 2018. Vol. 59, p. S64-S65
National Category
Public Health, Global Health, Social Medicine and Epidemiology
Identifiers
URN: urn:nbn:se:bth-16918ISI: 000439917500146OAI: oai:DiVA.org:bth-16918DiVA, id: diva2:1240303
Available from: 2018-08-21 Created: 2018-08-21 Last updated: 2018-08-21Bibliographically approved

Open Access in DiVA

No full text in DiVA

Authority records BETA

Sanmartin Berglund, Johan

Search in DiVA

By author/editor
Sanmartin Berglund, Johan
By organisation
Department of Health
In the same journal
Der Internist
Public Health, Global Health, Social Medicine and Epidemiology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 73 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf